Allworth Financial LP Acquires 3,442 Shares of GE HealthCare Technologies Inc. $GEHC

Allworth Financial LP increased its stake in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 4.4% in the 2nd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 81,764 shares of the company’s stock after purchasing an additional 3,442 shares during the period. Allworth Financial LP’s holdings in GE HealthCare Technologies were worth $6,056,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of GEHC. N.E.W. Advisory Services LLC acquired a new position in GE HealthCare Technologies in the first quarter valued at about $25,000. Bogart Wealth LLC boosted its position in GE HealthCare Technologies by 260.0% during the first quarter. Bogart Wealth LLC now owns 342 shares of the company’s stock valued at $28,000 after purchasing an additional 247 shares during the last quarter. Gladwyn Financial Advisors Inc. acquired a new position in GE HealthCare Technologies during the second quarter worth $34,000. Game Plan Financial Advisors LLC lifted its stake in GE HealthCare Technologies by 295.3% in the 2nd quarter. Game Plan Financial Advisors LLC now owns 502 shares of the company’s stock valued at $37,000 after purchasing an additional 375 shares during the last quarter. Finally, Zions Bancorporation National Association UT bought a new position in shares of GE HealthCare Technologies during the 1st quarter worth approximately $42,000. 82.06% of the stock is owned by institutional investors.

GE HealthCare Technologies Trading Down 0.1%

NASDAQ:GEHC opened at $73.41 on Wednesday. GE HealthCare Technologies Inc. has a 52 week low of $57.65 and a 52 week high of $94.80. The firm has a 50-day moving average price of $75.15 and a two-hundred day moving average price of $73.64. The company has a debt-to-equity ratio of 0.83, a quick ratio of 0.95 and a current ratio of 1.18. The firm has a market cap of $33.44 billion, a price-to-earnings ratio of 15.17, a price-to-earnings-growth ratio of 2.76 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last released its earnings results on Wednesday, October 29th. The company reported $1.07 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.05 by $0.02. The company had revenue of $5.14 billion during the quarter, compared to analyst estimates of $5.07 billion. GE HealthCare Technologies had a return on equity of 22.52% and a net margin of 10.94%.GE HealthCare Technologies’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the prior year, the company posted $1.14 earnings per share. GE HealthCare Technologies has set its FY 2025 guidance at 4.510-4.630 EPS. On average, equities analysts expect that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Shareholders of record on Friday, October 24th will be given a $0.035 dividend. The ex-dividend date of this dividend is Friday, October 24th. This represents a $0.14 annualized dividend and a yield of 0.2%. GE HealthCare Technologies’s payout ratio is currently 2.89%.

Analyst Upgrades and Downgrades

GEHC has been the topic of a number of research reports. Wells Fargo & Company decreased their price objective on GE HealthCare Technologies from $89.00 to $87.00 and set an “overweight” rating on the stock in a report on Thursday, October 30th. Wall Street Zen lowered shares of GE HealthCare Technologies from a “buy” rating to a “hold” rating in a research report on Saturday, September 20th. BTIG Research set a $87.00 price target on shares of GE HealthCare Technologies in a report on Wednesday, October 29th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of GE HealthCare Technologies in a research note on Tuesday, October 14th. Finally, Citigroup cut GE HealthCare Technologies from a “buy” rating to a “neutral” rating and cut their price target for the stock from $93.00 to $83.00 in a report on Tuesday, October 7th. Six investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus price target of $86.10.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.